Related Experiment Video
Updated: Jan 8, 2026

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
Published on: March 19, 2018
Marking a path to transplant tolerance
Vicki Seyfert-Margolis1, Laurence A Turka
1Department of Medicine, University of California, San Francisco, San Francisco, California, USA. vseyfert@immunetolerance.org
Researchers identified biomarkers to predict immune tolerance in liver transplant recipients. This could allow for reduced immunosuppression, improving patient quality of life and guiding new tolerance therapies.
Area of Science:
- Immunology
- Transplantation Medicine
- Biomarker Discovery
Background:
- Long-term survival of organ transplants (allografts) necessitates continuous immunosuppression.
- Current immunosuppression strategies carry significant adverse effects, impacting recipients' quality of life.
Purpose of the Study:
- To identify biomarkers predicting immune tolerance in liver transplant recipients.
- To enable the withdrawal of immunosuppression in select patients.
- To guide the development of novel tolerogenic therapies.
Main Methods:
- Analysis of biomarker profiles in liver transplant recipients.
- Correlation of biomarker profiles with the development of immune tolerance.
- Prospective patient selection for immunosuppression withdrawal based on biomarkers.
Main Results:
- A specific biomarker profile was identified that predicts immune tolerance.
- This profile allows for the prospective selection of patients suitable for immunosuppression withdrawal.
- These findings offer a pathway to reduce long-term immunosuppression needs.
Conclusions:
- Biomarker discovery offers a novel approach to managing transplant recipients.
- Identifying tolerance biomarkers can facilitate immunosuppression withdrawal, enhancing patient outcomes.
- This research may lead to therapies promoting allograft acceptance without long-term immunosuppression.
Related Concept Videos
06:40An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
08:40Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
11:47Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
11:56A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
14:55Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

